Medicine and Dentistry
Adrenal Disease
21%
Adrenalectomy
31%
Aldosterone
17%
Cancer
29%
Computer Assisted Tomography
21%
Cytotechnology
18%
Decision Making
23%
Diagnosis
12%
Differentiated Thyroid Cancer
32%
Disease
58%
Echography
13%
Fine-Needle Aspiration
18%
Frailty
13%
Gene Therapy
13%
Hazard Ratio
27%
Health Care Cost
20%
Hormone Determination
23%
Hydrocortisone
16%
Hyperparathyroidism
17%
Hypocalcaemia
23%
Kidney Graft
12%
Kidney Transplantation
27%
Malignant Neoplasm
17%
Medicare
24%
Metastasectomy
21%
Metastatic Melanoma
14%
Neck Dissection
13%
Neoplasm
23%
Nephropathy
21%
Pancreas Adenocarcinoma
16%
Papillary Thyroid Cancer
43%
Parathyroid Hormone
35%
Parathyroidectomy
57%
Prevalence
23%
Primary Hyperaldosteronism
32%
Primary Hyperparathyroidism
21%
Prospective Study
27%
Quality Improvement
13%
Renal Failure
12%
Secondary Hyperparathyroidism
67%
Surgeon
39%
Surgery
32%
Symptom
27%
Tertiary Hyperparathyroidism
16%
Thyroid Cancer
42%
Thyroid Gland
68%
Thyroid Nodule
44%
Thyroid Surgery
18%
Thyroidectomy
100%
Tumor Infiltrating Lymphocyte
21%
Keyphrases
ABCG2
10%
Adjusted Hazard Ratio
19%
Adrenal Vein Sampling
21%
Adult Patients
15%
Black Men
12%
Clinical Outcomes
12%
Cognitive Decline
21%
Cognitive Impairment
13%
Computed Tomography
14%
Confidence Interval
44%
Dementia Risk
24%
Dialysis Patients
23%
Gene Therapy
13%
Graft Loss
12%
High Risk
11%
Hyperaldosteronism
21%
Hyperparathyroidism
13%
Hypocalcemia
19%
Incident Dementia
13%
Intact Parathyroid Hormone (iPTH)
19%
Kidney Failure
11%
Kidney Transplant
17%
Kidney Transplant Recipients
33%
Kidney Transplantation
18%
Medicare Coverage
21%
Melanoma
12%
Metastatic Melanoma
19%
Older Adults
74%
Older Patients
20%
Papillary Thyroid Cancer
21%
Papillary Thyroid Carcinoma
21%
Parathyroid Hormone Levels
28%
Parathyroidectomy
56%
Particulate Matter Exposure
12%
Prevalence Factors
21%
Rate of Increase
21%
Retrospective Cohort Study
12%
Risk Factors
30%
Secondary Hyperparathyroidism
78%
Single Institution
15%
Single Institution Study
23%
Surgical Decision Making
21%
Tertiary Hyperparathyroidism
17%
Thyroid Nodule
13%
Thyroidectomy
66%
Total Thyroidectomy
12%
Transplantation
12%
Tumor-infiltrating Lymphocyte Therapy
12%
Tumor-infiltrating Lymphocytes
21%
United States Renal Data System (USRDS)
16%